ArticleCancer immunology, immunotherapy : CII2021

Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer.

Yuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.